(Q45354034)

13 December 2017

title

Persistence of antimuscarinic drug use. (English)

1 reference

13 December 2017

2

1 reference

13 December 2017

1

Søren Brostrøm

1 reference

13 December 2017

publication date

24 December 2008

1 reference

European Journal of Clinical Pharmacology

13 December 2017

published in

1 reference

13 December 2017

volume

65

1 reference

13 December 2017

issue

3

1 reference

13 December 2017

page(s)

309-314

1 reference

A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial

13 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0600-9

Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?

21 January 2018

1 reference

12 December 2020

The Danish prescription registries.

1 reference

12 December 2020

Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension study

1 reference

12 December 2020

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

1 reference

12 December 2020

Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome

1 reference

12 December 2020

Anticholinergic drugs versus placebo for overactive bladder syndrome in adults

1 reference

12 December 2020

Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder

1 reference

12 December 2020

The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization

1 reference

12 December 2020

Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the california medicaid program

1 reference

12 December 2020

Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study

1 reference

12 December 2020

How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study

1 reference

12 December 2020

Templates for analysis of individual-level prescription data

1 reference

12 December 2020

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

1 reference

12 December 2020

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability

1 reference

12 December 2020

Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder

1 reference

12 December 2020

Persistence with overactive bladder pharmacotherapy in a Medicaid population.

1 reference

12 December 2020

10.1007/S00228-008-0600-9

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1033828854

0 references

1 reference